TAG:
myriad genetics
Lab News Briefs
By Robert Michel | From the Volume XXXI, No. 3 – February 26, 2024 Issue
New York Times Reviews DNA Testing Kits for Its Readers It’s a sign of the times when The New York Times considers it useful to conduct and publish a review of DNA ancestry testing kits to guide readers. AncestryDNA of Lehi, Utah, was picked as “the most eff…
February 26, 2024, Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXI, No. 3 – February 26, 2024 Issue
Following an investment of $1.75 million, officials at University of Maine at Augusta (UMA) opened a new lab facility this month that allows it to double the number of medical laboratory technicians it can train, from eight to 10 to as many as 20. In its coverage of the new training …
January 16, 2024, Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXI, Number 1 – January 16, 2024 Issue
If a patient’s genetic test generates results that are actionable, will that patient move forward with treatment? That is one question asked by researchers in a study led by Vanderbilt University Medical Center that was published in the American Journal of Human Genetics. …
Clinisys CEO Discusses Strategic Changes Labs Need to Make
By Robert Michel | From the Volume XXX, Number 15 – October 23, 2023 Issue
“Today, we predict that the next storm is about ready to happen, and it will involve clinical laboratories and anatomic pathology practices.” —Michael Simpson CEO SUMMARY: In this exclusive Q&A with The Dark Report, Clinisys CEO Michael Simpson describes the …
February 13, 2023, Intelligence: Late-Breaking Lab News
By Scott Wallask | From the Volume XXX No. 3 – February 13, 2023 Issue
Laboratory leaders should prepare now for the end of the federal public health emergency (PHE) for SARS-CoV-2. The White House announced the PHE would cease on May 11. One big change is that patients covered by Medicare, Medicaid, or private insurance may pay higher costs for COVID-19 t…
Ravgen Gets $272.5 Million Verdict against Labcorp
By Scott Wallask | From the Volume XXIX, No. 15 – October 31, 2022 Issue
CEO SUMMARY: In September, a jury returned a $272.5 million verdict against Labcorp, representing royalties owed to biotech company Ravgen for infringement of its diagnostic genetic test patent. Soon after, Quest Diagnostics settled a similar lawsuit with Ravgen before its tri…
Myriad to Buy Counsyl, to Gain Presence in NIPS Test Sector
By Joseph Burns | From the Volume XXV No. 9 – June 18, 2018 Issue
LATE LAST MONTH, Myriad Genetics Inc. announced a definitive agreement to acquire Counsyl, Inc., an innovative genetic testing company in South San Francisco, Calif., for $375 million. In a deal that is expected to close by early next year, Myriad will use a combinat…
Misinterpreted Gene Test Shows Lab Got it Right
By Joseph Burns | From the Volume XXIV No. 17 – December 11, 2017 Issue
CEO SUMMARY: It’s almost a case of man bites dog. In malpractice cases involving genetic test results, labs are often assumed to be at fault. But in a lawsuit filed in Oregon, healthcare providers are alleged to have misinterpreted a genetic test. As a consequence, a patient underwent m…
Some Labs Performing ADLTs May See Increased Medicare Fees
By Joseph Burns | From the Volume XXIV No. 15 – October 30, 2017 Issue
MIXED IN THE BAD NEWS concerning the proposed Clinical Laboratory Fee Schedule for 2018, there is some good news regarding what the federal Centers for Medicare and Medicaid Services proposes to pay for certain advanced diagnostic tests. After analyzing the proposed fee schedule, …
Ambry Genetics $800M Sale to Konica Minolta Is a Big Deal for Lab Industry
By Mary Van Doren | From the Volume XXIV No. 10 – July 17, 2017 Issue
This is an excerpt from a 2,026-word article in the July 17, 2017 issue of THE DARK REPORT. The complete article is available for a limited time to all readers, and available at all times to paid members of the Dark Intelligence Group. …
CURRENT ISSUE
Volume XXXI, No. 16 – November 25, 2024
Two different federal lawsuits that challenge the authority of the federal Food and Drug Administration (FDA) to regulate laboratory developed tests (LDTs) will be combined. Plaintiffs and the government in both cases agreed to move forward on this basis.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized
The Dark Report • 21806 Briarcliff Dr • Spicewood, TX 78669
Phone: 512-264-7103 • Toll Free Number: 800-560-6363
Email: info@darkreport.com
© 2024 The Dark Report. All rights reserved.